{"id":70799,"date":"2026-05-12T11:37:16","date_gmt":"2026-05-12T11:37:16","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70799"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"glow","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/glow\/","title":{"rendered":"GLOW Blend\uff08BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg\uff09"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 GLOW\u3068\u306f\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>GLOW<\/strong> \u306f\u3001\u5171\u540c\u914d\u5408\u3055\u308c\u305f3\u7a2e\u30da\u30d7\u30c1\u30c9\u30d6\u30ec\u30f3\u30c9\u3067\u3001 <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> 10 mg\u3001, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> 50 mg\u3001\u304a\u3088\u3073 <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> 10\u00a0mg in a single lyophilized vial. The combination covers three complementary regenerative mechanisms in one administration: BPC-157&#8217;s local angiogenic and growth-factor signalling, GHK-Cu&#8217;s copper-mediated dermal remodelling, and TB-500&#8217;s systemic G-actin-binding tissue migration. Each vial contains 70\u00a0mg of total peptide for clinical studies use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d44\u6210<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg\uff08\u8cea\u91cf\u6bd4 1:5:1\u3001\u5171\u88fd\u5264\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7dcf\u30da\u30d7\u30c1\u30c9\u8cea\u91cf10 mg\uff085 mg + 5 mg\uff09<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u7dcf\u30da\u30d7\u30c1\u30c9\u8cea\u91cf 70mg<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Component CAS Numbers<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">137525-51-0\uff08BPC-157\uff09\/ 49557-75-7\uff08GHK-Cu\uff09\/ 77591-33-4\uff08TB-500 \/ \u30c1\u30e2\u30b7\u30f3 \u03b2-4\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4f5c\u7528\u6a5f\u5e8f\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">VEGF\u3092\u4ecb\u3057\u305f\u8840\u7ba1\u65b0\u751f\uff08BPC-157\uff09+ \u9285\u3092\u4ecb\u3057\u305f\u771f\u76ae\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\uff08GHK-Cu\uff09+ G-\u30a2\u30af\u30c1\u30f3\u7d50\u5408\u306b\u3088\u308b\u5168\u8eab\u6027\u7d44\u7e54\u904a\u8d70\uff08TB-500\uff09\u2014 3\u3064\u306e\u76f8\u88dc\u7684\u306a\u518d\u751f\u7d4c\u8def<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u5171\u88fd\u5264\u7c89\u672b\uff08\u7d50\u5408\u3057\u305fCu\u306b\u3088\u308b\u6de1\u3044\u9752\u8272\u306e\u8272\u5408\u3044<sup>2+<\/sup>)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08\u5404\u6210\u5206HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u4f7f\u7528\u6642\u5728\u5eab\u306f2\uff5e8\u2103\uff08\u51b7\u8535\uff09\u306b\u4fdd\u7ba1\u3002\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306b\u306f\u221220\u2103\u3002\u518d\u6eb6\u89e3\u5f8c\uff1a2\uff5e8\u2103\u3067\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u30023\u7a2e\u985e\u306e\u30da\u30d7\u30c1\u30c9\u306f\u3059\u3079\u3066\u540c\u3058\u30d0\u30a4\u30a2\u30eb\u304b\u3089\u540c\u6642\u306b\u518d\u69cb\u6210\u3055\u308c\u307e\u3059\u3002\u518d\u69cb\u6210\u3055\u308c\u305f\u6eb6\u6db2\u306f\u3001\u7d50\u5408\u3057\u305fCu\u304b\u3089<sup>2+<\/sup> GHK-Cu \u306e\u3002<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>GLOW\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>GLOW<\/strong> is a pharmaceutical-grade co-formulated three-peptide blend that combines <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> \uff08\u8eab\u4f53\u4fdd\u8b77\u5316\u5408\u7269157\uff09\u3001, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> \uff08\u30b0\u30ea\u30b7\u30eb-\u30d2\u30b9\u30c1\u30b8\u30eb-\u30ea\u30b7\u30f3\u9285(II)\u932f\u4f53\uff09\u3001\u304a\u3088\u3073 <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> (Thymosin Beta-4 fragment) in a single lyophilized vial at a 1:5:1 mass ratio \u2014 10\u00a0mg BPC-157, 50\u00a0mg GHK-Cu, and 10\u00a0mg TB-500 per vial, for a total of 70\u00a0mg peptide mass. The three peptides represent three of the most cited regenerative-compounds in the published literature, each acting on a different molecular axis: BPC-157 on local angiogenesis and growth-factor signalling, GHK-Cu on copper-mediated dermal remodelling and antioxidant signalling, and TB-500 on systemic G-actin-binding and cell migration. The strategic rationale for the GLOW blend is <strong>\u76f8\u88dc\u7684\u3067\u91cd\u8907\u3057\u306a\u3044\u6a5f\u5e8f<\/strong> across three regenerative axes. Each component peptide has a distinct molecular target and tissue-distribution pattern, so co-administration covers a broader range of studies endpoints than any single component alone. The blend is intended for studies that benefits from simultaneous activation of all three pathways \u2014 a use case distinct from studies designs that require independent dosing of each component peptide. For studies that needs <strong>\u72ec\u7acb\u3057\u305f\u6295\u4e0e<\/strong> \u5404\u30da\u30d7\u30c1\u30c9\u306e\uff08\u7570\u306a\u308b\u7528\u91cf\u3001\u7570\u306a\u308b\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u3001\u7570\u306a\u308b\u5a92\u4f53\u88fd\u5264\uff09\u3001\u6210\u5206\u306f\u5358\u4f53\u30d0\u30a4\u30a2\u30eb\u3068\u3057\u3066\u3082\u7528\u610f\u3055\u308c\u3066\u3044\u307e\u3059\uff1a <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a>, Rosu HDL <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a>. \u3002\u5225\u306e3\u30d0\u30a4\u30a2\u30eb\u30d0\u30f3\u30c9\u30eb \u2014 <a href=\"https:\/\/medsbase.com\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/a> (BPC-157 + TB-500 + bacteriostatic water shipped together as three separate vials) \u2014 provides another alternative for studies requiring per-component dose-flexibility. The GLOW co-formulation is specifically for studies at the fixed 1:5:1 mass ratio with single-vial reconstitution. GLOW is supplied as a high-purity lyophilized blend for reconstitution with bacteriostatic water. The reconstituted solution retains a faint blue tint from the bound Cu<sup>2+<\/sup> GHK-Cu\u6210\u5206\u306e \u2014 \u9285\u306e\u914d\u4f4d\u304c\u51cd\u7d50\u4e7e\u71e5\u3068\u518d\u69cb\u6210\u3092\u901a\u3058\u3066\u640d\u306a\u308f\u308c\u3066\u3044\u306a\u3044\u3053\u3068\u3092\u793a\u3059\u6709\u7528\u306a\u5b9a\u6027\u7684\u6307\u6a19\u3067\u3059\u3002GLOW\u306f <strong>\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u305b\u3093<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use as a combination or as any of its component peptides. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 3\u3064\u306e\u76f8\u88dc\u7684\u306a\u518d\u751f\u7d4c\u8def<\/h2>\n<p>GLOW\u914d\u5408\u88fd\u5264\u306e\u85ac\u7406\u5b66\u7684\u306a\u7279\u7570\u6027\u306f\u3001 <strong>3\u8ef8\u306e\u4f5c\u7528\u6a5f\u5e8f\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb<\/strong> \u2014 each component activates a fundamentally different regenerative pathway, and the three are non-overlapping at the molecular level. Published studies on each component has established the mechanism in detail; the combination simply delivers all three in a single administration:<\/p>\n<ul>\n<li><strong>BPC-157\uff0810 mg\uff09\u2014 \u5c40\u6240\u7d44\u7e54\u4fee\u5fa9\u306e\u305f\u3081\u306eVEGF\/NO\/GH\u53d7\u5bb9\u4f53\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054<\/strong> \u2014 The 15-amino-acid pentadecapeptide derived from gastric juice upregulates VEGFR2 (driving new capillary formation at injury sites), enhances endothelial nitric oxide synthase activity (protecting vascular endothelium), and increases growth-hormone receptor expression on fibroblasts and tenocytes (driving collagen synthesis). Most-cited signal: tendon, ligament, gut barrier, and skeletal muscle recovery. Acts more locally than systemic at the injection site.<\/li>\n<li><strong>GHK-Cu\uff0850 mg\uff09\u2014 \u9285\u3092\u4ecb\u3057\u305f\u76ae\u819a\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\u304a\u3088\u3073\u6297\u9178\u5316\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054<\/strong> \u2014 Cu<sup>2+<\/sup>-coordinated tripeptide delivers copper as an enzyme cofactor for lysyl oxidase (collagen\/elastin cross-linking) and superoxide dismutase (oxidative-stress buffering) while signalling on dermal fibroblasts and keratinocytes. Most-cited signal: skin remodelling, wound healing, anti-aging in connective-tissue studies, hair follicle support, copper-axis pharmacology. Higher mass loading (50\u00a0mg in the blend) reflects the larger doses typical of copper-peptide studies vs the microgram-range doses of the other two components.<\/li>\n<li><strong>TB-500\uff0810 mg\uff09\u2014 G-\u30a2\u30af\u30c1\u30f3\u306e\u9694\u96e2\u3068\u5168\u8eab\u6027\u7d30\u80de\u904a\u8d70<\/strong> \u2014 The 43-amino-acid thymic peptide is the canonical systemic regenerative compound, binding monomeric G-actin and modulating actin dynamics to drive cell migration, particularly at injury sites. Most-cited signal: systemic muscle and cardiac recovery, vascular repair, and broad systemic distribution that complements BPC-157&#8217;s more localised action. Acts as the &#8220;systemic arm&#8221; to BPC-157&#8217;s &#8220;local arm&#8221;.<\/li>\n<\/ul>\n<p>3\u3064\u306e\u7d4c\u8def\u306f <strong>\u6a5f\u5e8f\u7684\u306b\u76f8\u88dc\u7684<\/strong>, not redundant: BPC-157 acts locally on the injury site, TB-500 distributes systemically and supports cell migration globally, and GHK-Cu provides copper-cofactor delivery and dermal-tissue-specific signalling. Co-administering the three in study models covers angiogenesis (BPC-157), systemic recovery (TB-500), and dermal-tissue remodelling (GHK-Cu) simultaneously \u2014 a broader studies endpoint coverage than any single component alone. All three peptides have well-tolerated profiles in published preclinical studies, and combination protocols are described in some published studies models of multi-axis tissue regeneration. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GLOW co-formulation is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Multi-axis tissue regeneration<\/strong> \u2014 preclinical models combining systemic and local regenerative endpoints; angiogenesis + cell migration + dermal remodelling in single studies designs<\/li>\n<li><strong>Wound healing studies<\/strong> \u2014 \u76ae\u819a\u5275\u50b7\u30e2\u30c7\u30eb\uff08\u5168\u5c64\u3001\u90e8\u5206\u5c64\u3001\u71b1\u50b7\uff09\u3001\u5275\u50b7\u53ce\u7e2e\u52d5\u614b\u3001\u8089\u82bd\u7d44\u7e54\u5f62\u6210\u3001\u7622\u75d5\u7d44\u7e54\u306e\u7279\u6027\u8a55\u4fa1\uff1b\u3088\u308a\u5305\u62ec\u7684\u306a\u591a\u8ef8\u30a2\u30d7\u30ed\u30fc\u30c1\u306e\u4e00\u3064\u3067\u3059<\/li>\n<li><strong>\u8171\u3001\u976d\u5e2f\u3001\u8edf\u90e8\u7d44\u7e54\u306e\u56de\u5fa9<\/strong> \u2014 rodent Achilles transection models, medial-collateral-ligament rupture studies; published BPC-157 + TB-500 literature is extensive, with the GHK-Cu addition providing copper-cofactor support for collagen cross-linking<\/li>\n<li><strong>Skin remodelling and dermal studies<\/strong> \u2014 collagen and elastin synthesis, dermal-fibroblast proliferation, photo-aging studies; the GHK-Cu component dominates this studies domain<\/li>\n<li><strong>Comparative co-formulation studies<\/strong> \u2014 \u5358\u72ec\u7fa4\u3068\u306e\u76f4\u63a5\u6bd4\u8f03\uff1b\u4e09\u8ef8\u4f75\u7528\u306b\u304a\u3051\u308b\u76f8\u52a0\u52b9\u679c\u3068\u76f8\u4e57\u52b9\u679c\u306e\u5206\u6790 <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a>, Rosu HDL <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> \u30a2\u30fc\u30e0\uff1b3\u8ef8\u306e\u7d44\u307f\u5408\u308f\u305b\u306b\u308f\u305f\u308b\u76f8\u52a0\u52b9\u679c\u3068\u76f8\u4e57\u52b9\u679c\u306e\u89e3\u6790<\/li>\n<li><strong>Vascular and cardiac recovery<\/strong> \u2014 BPC-157\u306e\u8840\u7ba1\u65b0\u751f\u4fc3\u9032\u30b7\u30b0\u30ca\u30eb\u3068TB-500\u306e\u904a\u8d70\u4fc3\u9032\u30b7\u30b0\u30ca\u30eb\u306e\u7d44\u307f\u5408\u308f\u305b\u306f\u3001\u8840\u7ba1\u4fee\u5fa9\u3084\u5fc3\u865a\u8840\u30e2\u30c7\u30eb\u306b\u9069\u3057\u3066\u3044\u307e\u3059\u3002<\/li>\n<li><strong>Anti-aging and longevity studies<\/strong> \u2014 published work on copper-peptide effects in dermal and connective-tissue aging, particularly relevant for the GHK-Cu component; combined with BPC-157 + TB-500 for broader tissue-aging studies designs<\/li>\n<li><strong>Inflammation and oxidative-stress studies<\/strong> \u2014 copper&#8217;s role as cofactor for superoxide dismutase plus the BPC-157 and TB-500 inflammation-modulating effects provide multi-axis anti-inflammatory studies coverage.<\/li>\n<\/ul>\n<p>\u3088\u308a\u5e83\u3044\u6587\u8108\u306b\u3064\u3044\u3066\u306f\u3001\u5f53\u793e\u306e\u5404 <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a>, Rosu HDL <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> \u6210\u5206\u30ec\u30d9\u30eb\u306e\u85ac\u7406\u306b\u95a2\u3059\u308b\u88fd\u54c1\u30da\u30fc\u30b8\u3001 <a href=\"https:\/\/medsbase.com\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/a> 3\u672c\u5225\u500b\u30d0\u30a4\u30a2\u30eb\u30bb\u30c3\u30c8\uff08BPC-157 + TB-500 + \u9759\u83cc\u6c34\uff09\u306e\u4ee3\u66ff\u54c1\u3001\u304a\u3088\u3073\u59c9\u59b9\u9285\u30da\u30d7\u30c1\u30c9 <a href=\"https:\/\/medsbase.com\/ja\/ahk-cu\/\">AHK-Cu<\/a> for hair-axis studies. Browse the full <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/a> \u5316\u5408\u7269\u9078\u629e\u306e\u305f\u3081\u306b\u3002 <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u69cb\u6210<\/h2>\n<p>MedsBase\u3067\u306fGLOW\u30d6\u30ec\u30f3\u30c9\u3092\u5358\u4e00\u306e\u5171\u88fd\u5264\u3068\u3057\u3066\u5728\u5eab\u3057\u3066\u3044\u307e\u3059\uff1a <strong>1\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308aBPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg<\/strong> \uff08\u8cea\u91cf\u6bd41:5:1\u3001\u7dcf\u30da\u30d7\u30c1\u30c9\u91cf70 mg\uff09\u3002\u30d0\u30a4\u30a2\u30eb\u306f10\u672c\u5165\u308a\u307e\u305f\u306f20\u672c\u5165\u308a\u30d1\u30c3\u30af\u5f62\u5f0f\u3067\u3001\u5b8c\u5168\u306a\u518d\u69cb\u6210\u30ac\u30a4\u30c0\u30f3\u30b9\u4ed8\u304d\u3067\u5165\u624b\u53ef\u80fd\u3067\u3059\uff1a<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u306e\u7d44\u6210<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard tri-axis regenerative-studies blend \u2014 angiogenesis + dermal remodelling + systemic cell migration in single administration<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u307e\u305f\u306f20\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three components are supplied at \u226599% HPLC purity (each verified individually) and pre-mixed in the same lyophilized vial. Because the three peptides have different dose ranges and different roles in the blend, the 1:5:1 mass ratio is fixed at manufacture. Users requiring different ratios should use the stand-alone <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a>, Rosu HDL <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> vials instead. Compared with purchasing the three components separately, the GLOW co-formulation offers a meaningful cost saving and the practical convenience of single-vial reconstitution at the fixed studies ratio. <\/p>\n<h2>\u6bd4\u8f03\uff1aGLOW\u30d6\u30ec\u30f3\u30c9 vs \u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/h2>\n<p>MedsBase carries two multi-peptide studies products that combine the same broader healing-peptide pharmacology in different packaging formats. The choice between them depends on studies design requirements:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GLOW Blend<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\"><a href=\"https:\/\/medsbase.com\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/a><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5305\u88c5\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5358\u4e00\u30d0\u30a4\u30a2\u30eb\u3001\u5171\u88fd\u5264<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3\u3064\u306e\u500b\u5225\u30d0\u30a4\u30a2\u30eb\u3092\u540c\u68b1\u767a\u9001<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u7d44\u6210<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BPC-157 5 mg + TB-500 5 mg + \u9759\u83cc\u6c34<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u6210\u5206\u6570<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3\u7a2e\u985e\u306e\u30da\u30d7\u30c1\u30c9\uff08\u9285\u30da\u30d7\u30c1\u30c9\u3092\u542b\u3080\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u7a2e\u985e\u306e\u30da\u30d7\u30c1\u30c9\uff0b\u6eb6\u89e3\u6db2\uff08\u9285\u30da\u30d7\u30c1\u30c9\u306a\u3057\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u7528\u91cf\u306e\u67d4\u8edf\u6027<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30d0\u30a4\u30a2\u30eb\u3054\u3068\u306b\u56fa\u5b9a\u3055\u308c\u305f1:5:1\u306e\u8cea\u91cf\u6bd4<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6210\u5206\u3054\u3068\u306e\u7528\u91cf\u306e\u72ec\u7acb\u6027<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u518d\u69cb\u6210<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u56de\u9650\u308a\u306e\u6eb6\u89e3<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30d0\u30a4\u30a2\u30eb\u3054\u3068\u306e\u518d\u69cb\u6210<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4f7f\u7528\u4f8b<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Convenience + fixed-ratio studies; broader 3-axis coverage including dermal remodelling<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dose-flexible studies; classic 2-axis healing focus (BPC + TB only)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Studies designs that require flexible per-component dosing or that don&#8217;t need the copper-peptide arm should use the <a href=\"https:\/\/medsbase.com\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/a>. Studies designs that benefit from the broader three-axis coverage (including dermal-tissue remodelling) and that are comfortable with the fixed 1:5:1 mass ratio should use the GLOW blend. Both options are pre-curated for the most-cited healing-peptide studies pharmacology \u2014 the difference is packaging format and component breadth. <\/p>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u77ed\u671f\u4f7f\u7528\u306e\u4f5c\u696d\u7528\u30b9\u30c8\u30c3\u30af\u3068\u3057\u3066\u3001\u51cd\u7d50\u4e7e\u71e5\u6e08\u307f\u30d0\u30a4\u30a2\u30eb\u306f\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u7ba1\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u672a\u958b\u5c01\u306e\u9577\u671f\u4fdd\u7ba1\u306e\u5834\u5408\u306f\u3001-20\u00b0C\u3067\u51cd\u7d50\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u4e7e\u71e5\u72b6\u614b\u306eGLOW\u5171\u88fd\u5264\u306f\u3001\u51b7\u8535\u4e0b\u3067\u6700\u957724\u30f6\u6708\u3001-20\u00b0C\u3067\u6700\u957736\u30f6\u6708\u9593\u5b89\u5b9a\u3067\u3059\u30023\u3064\u306e\u6210\u5206\u30da\u30d7\u30c1\u30c9\u306f\u3044\u305a\u308c\u3082\u3001\u51cd\u7d50\u4e7e\u71e5\u72b6\u614b\u3067\u975e\u5e38\u306b\u9069\u5408\u6027\u306e\u9ad8\u3044\u5b89\u5b9a\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u793a\u3057\u307e\u3059\u3002\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\u306b\u5bfe\u3057\u3066\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u3092\u7e70\u308a\u8fd4\u3055\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u9759\u83cc\u6c34\u3092\u6ce8\u5165\u3057\u3066\u304f\u3060\u3055\u3044\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff09\u3002\u30d0\u30a4\u30a2\u30eb\u306b\u306f\u7dcf\u30da\u30d7\u30c1\u30c9\u8cea\u91cf70 mg\u304c\u542b\u307e\u308c\u3066\u3044\u308b\u305f\u3081\u30012.0 mL\u306e\u518d\u69cb\u6210\u6db2\u3067\u7dcf\u30da\u30d7\u30c1\u30c9\u306e\u4f5c\u696d\u6fc3\u5ea6\u306f35 mg\/mL\u3068\u306a\u308a\u3001\u3053\u308c\u306fBPC-157 5 mg\/mL\u3001GHK-Cu 25 mg\/mL\u3001TB-500 5 mg\/mL\u306b\u76f8\u5f53\u3057\u307e\u3059\u3002\u9759\u304b\u306b\u5186\u3092\u63cf\u304f\u3088\u3046\u306b\u52d5\u304b\u3057\u3001 <strong>\u3057\u307e\u305b\u3093<\/strong> \u632f\u3089\u305a\u306b2\uff5e5\u5206\u9593\u653e\u7f6e\u3057\u3066\u5b8c\u5168\u306b\u6eb6\u89e3\u3055\u305b\u307e\u3059\u3002\u6b63\u3057\u304f\u518d\u69cb\u6210\u3055\u308c\u305f\u6eb6\u6db2\u306f\u3001\u900f\u660e\u3067\u3001 <strong>\u6de1\u3044\u9752\u8272<\/strong> \u7d50\u5408\u3057\u305fCu\u306b\u7531\u6765\u3059\u308b<sup>2+<\/sup> GHK-Cu\u6210\u5206\u306e\u2014 \u3053\u306e\u8272\u306f\u3001\u51cd\u7d50\u4e7e\u71e5\u3068\u518d\u69cb\u6210\u3092\u901a\u3058\u3066\u9285\u306e\u914d\u4f4d\u304c\u7dad\u6301\u3055\u308c\u3066\u3044\u308b\u3053\u3068\u3092\u793a\u3059\u6709\u7528\u306a\u5b9a\u6027\u6307\u6a19\u3067\u3059\u3002\u6fc1\u308a\u3001\u6c88\u6bbf\u3001\u307e\u305f\u306f\u9752\u8272\u304c\u8a8d\u3081\u3089\u308c\u306a\u3044\u5834\u5408\u306f\u554f\u984c\u304c\u3042\u308b\u3053\u3068\u3092\u793a\u3057\u3066\u304a\u308a\u3001\u7834\u68c4\u3057\u3066\u3082\u3046\u4e00\u5ea6\u304a\u8a66\u3057\u304f\u3060\u3055\u3044\u3002 <strong>\u5b8c\u5168\u306b\u518d\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u3001\u7121\u8272\u900f\u660e\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/strong> 2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u7ba1\u3057\u30013\u3064\u306e\u6210\u5206\u3059\u3079\u3066\u306e\u6700\u9069\u306a\u5b89\u5b9a\u6027\u3092\u5f97\u308b\u305f\u3081\u300130\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u30da\u30d7\u30c1\u30c9\u306e\u5b8c\u5168\u6027\u3092\u4f4e\u4e0b\u3055\u305b\u3001\u9285\u306e\u914d\u4f4d\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u5e38\u306b\u76f4\u5c04\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u6fc1\u308a\u3001\u6c88\u6bbf\u3001\u307e\u305f\u306f\u4e88\u60f3\u3055\u308c\u308b\u6de1\u3044\u9752\u8272\u3092\u8d85\u3048\u305f\u5909\u8272\u304c\u8a8d\u3081\u3089\u308c\u308b\u30d0\u30a4\u30a2\u30eb\u306f\u7834\u68c4\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>What is GLOW used for in studies?<\/h3>\n<p>GLOW is used in studies investigating multi-axis tissue regeneration \u2014 specifically protocols that benefit from simultaneous activation of three complementary regenerative pathways (BPC-157 angiogenesis + GHK-Cu dermal remodelling + TB-500 systemic cell migration) in a single administration. Common contexts include wound healing models, tendon and soft-tissue recovery, skin remodelling, vascular repair, anti-aging connective-tissue studies, and comparative co-formulation pharmacology. The pharmaceutical-grade GLOW sold here is <strong>\u3057\u307e\u305b\u3093<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>GLOW\u306e\u30d0\u30a4\u30a2\u30eb\u306b\u306f\u4f55\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u5404\u30d0\u30a4\u30a2\u30eb\u306b\u306f\u542b\u307e\u308c\u3066\u3044\u307e\u3059 <strong>BPC-157 10mg\u3001GHK-Cu 50mg\u3001TB-500 10mg<\/strong>, co-formulated and lyophilized together as a single powder. Total peptide mass per vial: 70\u00a0mg. The 1:5:1 mass ratio reflects the different studies-relevant dose ranges of the three components (BPC-157 and TB-500 are used in microgram-to-low-milligram doses; GHK-Cu is used in low-to-mid-milligram doses). All three peptides reconstitute simultaneously when bacteriostatic water is added. <\/p>\n<h3>GLOW\u306fPeptide Healing Stack\u3068\u3069\u306e\u3088\u3046\u306b\u7570\u306a\u308a\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u3053\u308c\u30892\u3064\u306e\u88fd\u54c1\u306f\u3001\u95a2\u9023\u3059\u308b\u6cbb\u7652\u30da\u30d7\u30c1\u30c9\u3092\u7d44\u307f\u5408\u308f\u305b\u3066\u3044\u307e\u3059\u304c\u3001\u5305\u88c5\u5f62\u614b\u304c\u7570\u306a\u308a\u307e\u3059\u3002 <strong>GLOW<\/strong> \u306f\u30013\u3064\u306e\u30da\u30d7\u30c1\u30c9\uff08BPC-157 + GHK-Cu + TB-500\uff09\u304c\u56fa\u5b9a\u6bd4\u73871:5:1\u3067\u5171\u306b\u88fd\u5264\u5316\u3055\u308c\u305f1\u672c\u306e\u30d0\u30a4\u30a2\u30eb\u3067\u3059\u3002\u305d\u306e <a href=\"https:\/\/medsbase.com\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/a> is three separate vials (BPC-157 + TB-500 + bacteriostatic water) shipped in one parcel. GLOW adds the copper-peptide arm and consolidates reconstitution; the Peptide Healing Stack offers per-component dose independence without the copper-peptide component. Choose based on whether your studies needs the dermal-remodelling axis (GLOW) or per-component dose flexibility (Peptide Healing Stack). <\/p>\n<h3>GLOW\u306f\u3001\u305d\u308c\u305e\u308c\u306e\u69cb\u6210\u30da\u30d7\u30c1\u30c9\u3068\u3069\u306e\u3088\u3046\u306b\u7570\u306a\u308a\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u5404\u6210\u5206\u306f\u5358\u54c1\u88fd\u54c1\u3068\u3057\u3066\u3082\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\uff1a <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a>, Rosu HDL <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a>. \u5358\u54c1\u30d0\u30a4\u30a2\u30eb\u3067\u306f\u3001\u6210\u5206\u3054\u3068\u306e\u7528\u91cf\u8abf\u7bc0\u3001\u30da\u30d7\u30c1\u30c9\u3054\u3068\u306b\u7570\u306a\u308b\u6295\u4e0e\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u3001\u304a\u3088\u3073\u30da\u30d7\u30c1\u30c9\u3054\u3068\u306b\u7570\u306a\u308b\u6eb6\u5a92\u88fd\u5264\u304c\u53ef\u80fd\u3067\u3059\u3002GLOW\u306e\u5171\u88fd\u5264\u306f\u8cea\u91cf\u6bd41:5:1\u306b\u56fa\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u5229\u4fbf\u6027\uff081\u56de\u306e\u518d\u69cb\u6210\u30011\u56de\u306e\u6ce8\u5c04\uff09\u3068\u30013\u6210\u5206\u3092\u5225\u3005\u306b\u8cfc\u5165\u3059\u308b\u5834\u5408\u3068\u6bd4\u8f03\u3057\u3066\u308f\u305a\u304b\u306a\u30b3\u30b9\u30c8\u524a\u6e1b\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002 <\/p>\n<h3>What is the typical GLOW dose?<\/h3>\n<p>Dose depends on the studies endpoint. Conservative protocols use 0.04\u00a0mL of a 35\u00a0mg\/mL reconstituted solution (~200\u00a0mcg BPC-157 + 1\u00a0mg GHK-Cu + 200\u00a0mcg TB-500 per administration) several times weekly. Higher-dose protocols scale up proportionally within the fixed 1:5:1 ratio. Users requiring different ratios should use the stand-alone components rather than the blend. <\/p>\n<h3>GLOW\u306fFDA\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>No. GLOW is not approved by the FDA, EMA, MHRA, or any other major regulator as a combination product. None of the three individual components (BPC-157, GHK-Cu, TB-500) have FDA approval for human therapeutic use either. GHK-Cu is incorporated into some cosmetic products under cosmetic-regulation frameworks, but none of the three peptides is approved as a drug. <\/p>\n<h3>GLOW\u6eb6\u6db2\u304c\u9752\u307f\u304c\u304b\u3063\u3066\u3044\u308b\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u304b\u3059\u304b\u306a\u9752\u307f\u306f\u3001\u7d50\u5408\u3057\u305fCu\u306b\u7531\u6765\u3057\u307e\u3059<sup>2+<\/sup> GHK-Cu\u6210\u5206\u306e \u2014 \u5177\u4f53\u7684\u306b\u306f\u3001Gly-His-Lys\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\u306b\u3088\u3063\u3066\u5f62\u6210\u3055\u308c\u308b\u5e73\u9762\u56db\u89d2\u5f62\u914d\u4f4d\u74b0\u5883\u306b\u304a\u3051\u308b\u9285\u306ed-d\u96fb\u5b50\u9077\u79fb\u306b\u7531\u6765\u3057\u307e\u3059\u3002\u8272\u306f\u3001\u9285\u914d\u4f4d\u304c\u7121\u50b7\u3067\u3042\u308b\u3053\u3068\u306e\u6709\u7528\u306a\u5b9a\u6027\u7684\u6307\u6a19\u3067\u3059\uff1a\u9069\u5207\u306b\u518d\u69cb\u6210\u3055\u308c\u305fGLOW\u6eb6\u6db2\u306f\u3001\u304b\u3059\u304b\u306a\u76ee\u306b\u898b\u3048\u308b\u9752\u307f\u3092\u793a\u3059\u306f\u305a\u3067\u3059\uff1b\u7121\u8272\u307e\u305f\u306f\u8584\u3044\u6eb6\u6db2\u306f\u3001\u9285\u306e\u55aa\u5931\u307e\u305f\u306fGHK-Cu\u6210\u5206\u306e\u5206\u89e3\u3092\u793a\u5506\u3057\u307e\u3059\u3002\u4ed6\u306e2\u3064\u306e\u30da\u30d7\u30c1\u30c9\uff08BPC-157\u3001TB-500\uff09\u306f\u8272\u306b\u5bc4\u4e0e\u3057\u307e\u305b\u3093\u3002 <\/p>\n<h3>GLOW\u306f\u3069\u306e\u3088\u3046\u306b\u4fdd\u7ba1\u3059\u3079\u304d\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\uff1a\u77ed\u671f\u4f7f\u7528\u306e\u4f5c\u696d\u7528\u30b9\u30c8\u30c3\u30af\u306f2\uff5e8\u00b0C\u3067\u51b7\u8535\u3001\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306f-20\u00b0C\u3067\u51b7\u51cd\u4fdd\u5b58\u3002\u518d\u69cb\u6210\u6eb6\u6db2\uff1a2\uff5e8\u00b0C\u3067\u51b7\u8535\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u6eb6\u6db2\u3092\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044 \u2014 \u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u30da\u30d7\u30c1\u30c9\u306e\u5b8c\u5168\u6027\u3092\u4f4e\u4e0b\u3055\u305b\u3001\u9285\u914d\u4f4d\u307e\u305f\u306f\u30da\u30d7\u30c1\u30c9\u9aa8\u683c\u306e\u5b89\u5b9a\u6027\u306e\u3044\u305a\u308c\u304b\u306b\u4e0d\u5747\u8861\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u5e38\u306b\u76f4\u5c04\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>GLOW\u3092\u518d\u69cb\u6210\u3059\u308b\u306b\u306f\u3069\u3046\u3059\u308c\u3070\u3088\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u4e0a\u8a18\u306e\u518d\u6eb6\u89e3\u624b\u9806\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3092\u30d0\u30a4\u30a2\u30eb\u306e\u5185\u58c1\u306b\u6cbf\u3063\u3066\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u5f53\u3066\u306a\u3044\u3088\u3046\u306b\uff09\u52a0\u3048\u3001\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30672\uff5e5\u5206\u9593\u7f6e\u304d\u307e\u3059\u3002 <strong>\u3057\u307e\u305b\u3093<\/strong> \u30d0\u30a4\u30a2\u30eb\u3092\u632f\u3063\u3066\u304f\u3060\u3055\u3044\u30023\u3064\u306e\u30da\u30d7\u30c1\u30c9\u306f\u3059\u3079\u3066\u540c\u3058\u30d0\u30a4\u30a2\u30eb\u304b\u3089\u540c\u6642\u306b\u518d\u69cb\u6210\u3055\u308c\u307e\u3059\u3002\u6b63\u3057\u304f\u518d\u69cb\u6210\u3055\u308c\u305f\u6eb6\u6db2\u306f\u900f\u660e\u3067\u3001\u304b\u3059\u304b\u306a\u9752\u307f\u3092\u5e2f\u3073\u3066\u3044\u307e\u3059\u3002\u30d0\u30a4\u30a2\u30eb\uff0b2.0 mL\u306e\u5e0c\u91c8\u6db2\u306e\u5834\u5408\u3001\u4f5c\u696d\u6fc3\u5ea6\u306fBPC-157 5 mg\/mL\u3001GHK-Cu 25 mg\/mL\u3001TB-500 5 mg\/mL\u3067\u3059\u3002 <\/p>\n<h3>MedsBase\u3067\u306f\u3069\u306e\u3088\u3046\u306a\u69cb\u6210\u306e\u88fd\u54c1\u3092\u53d6\u308a\u6271\u3063\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase\u3067\u306f\u3001GLOW\u3092\u5358\u4e00\u306e\u5171\u88fd\u5264\u3068\u3057\u3066\u53d6\u308a\u6271\u3063\u3066\u3044\u307e\u3059\uff1a1\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308aBPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg\uff08\u7dcf\u30da\u30d7\u30c1\u30c970 mg\u3001\u8cea\u91cf\u6bd41:5:1\u3001\u51cd\u7d50\u4e7e\u71e5\u54c1\uff09\u3002\u30d0\u30a4\u30a2\u30eb\u306f10\u30d0\u30a4\u30a2\u30eb\u5165\u308a\u307e\u305f\u306f20\u30d0\u30a4\u30a2\u30eb\u5165\u308a\u306e\u30d1\u30c3\u30af\u30b5\u30a4\u30ba\u3067\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u5404\u6210\u5206\u306f\u500b\u5225\u306bHPLC\u7d14\u5ea699%\u4ee5\u4e0a\u3067\u3042\u308b\u3053\u3068\u304c\u78ba\u8a8d\u3055\u308c\u3066\u304a\u308a\u3001\u5206\u6790\u8a3c\u660e\u66f8\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u5165\u624b\u53ef\u80fd\u3067\u3059\u3002 <\/p>\n<h3>\u4ee3\u308f\u308a\u306bGLOW\u306e\u6210\u5206\u3092\u5225\u3005\u306b\u8cfc\u5165\u3067\u304d\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u306f\u3044 \u2014 MedsBase\u3067\u306f\u30013\u7a2e\u985e\u306e\u69cb\u6210\u30da\u30d7\u30c1\u30c9\u3059\u3079\u3066\u3092\u5358\u72ec\u88fd\u54c1\u3068\u3057\u3066\u53d6\u308a\u6271\u3063\u3066\u3044\u307e\u3059\uff1a <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> 2\/5\/10 mg\u306e\u30d0\u30a4\u30a2\u30eb\u3067\u3001, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a>, Rosu HDL <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> in 2\/5\/10\u00a0mg vials. Separate vials are useful if protocols require dose ratios other than the fixed 1:5:1 GLOW ratio, or if users want different scheduling per peptide. The co-formulated GLOW blend offers convenience and cost savings for studies at the 1:5:1 ratio. <\/p>\n<h3>Does GLOW cause side reported effects?<\/h3>\n<p>All three component peptides have well-tolerated profiles in published preclinical studies at typical doses. The most consistent finding for the combination is the same as for the individual components: local injection-site reactions, occasional flushing at higher doses, and (rarely) modest skin discolouration at the injection site from copper deposition (from the GHK-Cu component). Systemic adverse effects are uncommon in published preclinical literature for any of the three peptides. <\/p>\n<h3>How long does GLOW take to show effects in preclinical studies?<\/h3>\n<p>Effect onset varies by studies endpoint. Local wound-healing and tissue-recovery effects are typically measurable within 7\u201314 days of regular dosing. Skin-remodelling effects (collagen synthesis, dermal-fibroblast activity) accumulate over 4\u20138 weeks. Systemic regenerative effects mediated by TB-500 develop over similar timescales. The combined three-axis profile produces a broader endpoint coverage than any single component, but the kinetics for each axis follow the timeline of the respective component peptide. <\/p>\n<h3>GLOW\u3092\u6d77\u5916\u914d\u9001\u3067\u6ce8\u6587\u3067\u304d\u307e\u3059\u304b\uff1f<\/h3>\n<p>Yes. MedsBase ships GLOW worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. All orders ship in temperature-controlled packaging with full tracking and are covered by our <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\">\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Tissue Regeneration, Wound Healing, and Recovery Studies<\/h2>\n<ul>\n<li><a href=\"\/ja\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 \u8eab\u4f53\u4fdd\u8b77\u5316\u5408\u7269 \u2014 GLOW\u306e\u5c40\u6240\u8840\u7ba1\u65b0\u751f\u6210\u5206\u3001\u5358\u72ec\u30d0\u30a4\u30a2\u30eb<\/li>\n<li><a href=\"\/ja\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 \u9285\u30c8\u30ea\u30da\u30d7\u30c1\u30c9 \u2014 GLOW\u306e\u76ae\u819a\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\u6210\u5206\u3001\u5358\u72ec\u30d0\u30a4\u30a2\u30eb<\/li>\n<li><a href=\"\/ja\/tb-500\/\"><strong>TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf-4\uff09<\/strong><\/a> \u2014 \u5168\u8eab\u6027\u6cbb\u7652\u30d5\u30e9\u30b0\u30e1\u30f3\u30c8 \u2014 GLOW\u306e\u5168\u8eab\u6027\u7d30\u80de\u904a\u8d70\u6210\u5206<\/li>\n<li><a href=\"\/ja\/peptide-healing-stack\/\"><strong>\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/strong><\/a> \u2014 \u9285\u30da\u30d7\u30c1\u30c9\u3092\u542b\u307e\u306a\u3044\u3001\u4ee3\u66ff\u306e3\u30d0\u30a4\u30a2\u30eb\u30d0\u30f3\u30c9\u30eb\uff08BPC + TB + BAC\u6c34\uff09<\/li>\n<li><a href=\"\/ja\/ahk-cu\/\"><strong>AHK-Cu<\/strong><\/a> \u2014 Sister copper peptide to GHK-Cu \u2014 hair follicle compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore the regenerative-peptide studies landscape<\/strong><\/p>\n<p style=\"margin: 0;\">\u3059\u3079\u3066\u3092\u95b2\u89a7 <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\"><strong>\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/strong><\/a>, \u3001\u95a2\u9023\u3059\u308b\u518d\u751f\u5316\u5408\u7269\u3068\u3057\u3066\u306f <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> \uff08\u5c40\u6240\u8840\u7ba1\u65b0\u751f\uff09, <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> \uff08\u5168\u8eab\u6027\u7d30\u80de\u904a\u8d70\uff09, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> \uff08\u76ae\u819a\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\uff09\u3001\u304a\u3088\u3073\u4ee3\u66ff\u306e <a href=\"https:\/\/medsbase.com\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af<\/a> \u30d0\u30f3\u30c9\u30eb\u3002<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 3\u7a2e\u30da\u30d7\u30c1\u30c9\u914d\u5408\u306e\u518d\u751f\u30d6\u30ec\u30f3\u30c9<br \/>\n\u2705 BPC-157\uff0810mg\uff09 + GHK-Cu\uff0850mg\uff09 + TB-500\uff0810mg\uff09<br \/>\n\u2705 \u5c40\u6240\u7684\u306a\u8840\u7ba1\u65b0\u751f\uff0b\u76ae\u819a\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\uff0b\u5168\u8eab\u6027\u306e\u7d30\u80de\u904a\u8d70<br \/>\n\u2705 1\u30d0\u30a4\u30a2\u30eb\u30011\u56de\u306e\u518d\u6eb6\u89e3<br \/>\n\u2705 1\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a\u7dcf\u30da\u30d7\u30c1\u30c9\u91cf70mg<\/p>\n<p><strong>GLOW<\/strong> \u914d\u5408\u30da\u30d7\u30c1\u30c9\u88fd\u5264\u3067\u3059\u3002<\/p>","protected":false},"featured_media":70957,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5449,6291,5441,5442],"class_list":["post-70799","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bpc-157","product_tag-ghk-cu","product_tag-glow","product_tag-peptide","product_tag-tb-500","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/70799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=70799"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70957"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=70799"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=70799"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=70799"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=70799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}